Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressinum for Portal Vein Pressure After Liver Resection
NCT03352349Phase 2Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of terlipressin in Portal Hypertension (PH), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Change of Portal vein pressure at 8 months. Status: unknown.
02
Drugs
terlipressin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT03352349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03352349.